Targeted therapy is a type of cancer treatment in which the patient receives a specific chemical compound to attack a specific type of tumor. This drug is often a small molecule that can penetrate a cell’s membrane and interact with its target within it. Typically, it is designed to interfere with a specific protein’s enzymatic activity. The chemicals used in targeted cancer therapies are marketed as drugs under several different names. For instance, STI-571 became known as imatinib and is marketed by Novartis under the name Gleevec. Various drug names provide clues about the type of chemical compound and the target cellular structure that it is able to target.
Some side effects of targeted therapy include nausea and vomiting, as well as mouth sores and rashes. In rare cases, patients may also experience bleeding in their stomach and intestines. Some of these side effects may require medical intervention, while others may persist or become permanent. As with any type of treatment, it is important to report any changes to the healthcare provider as soon as possible. One drug in this class is known as bevacizumab. This drug prevents the growth of new blood vessels in the body and kills cancer cells by cutting them off.
Latest report available at Coherent Market Insights indicates that, Targeted Therapy Market is estimated to be valued at US$ 98.6 Bn in 2021 and is expected to exhibit a CAGR of 9.0% during the forecast period (2021-2028).
One of the most common side effects of targeted therapy is that it can become ineffective after a while. This is due to cancer finding a new way to outsmart it. If this happens, repeat genomic testing is necessary to identify whether the tumor has outsmarted the drug. These medications can be administered in pill form or via intravenous infusion, and may also be given in combination with other cancer treatments. They are made up of small molecules that can enter the cell easily and interfere with molecules inside or on the surface.
Drugs that target cancer cells work by interfering with specific molecules or proteins inside them. These drugs attack these molecules, stopping the growth and spread of cancer cells while sparing healthy cells. This type of cancer therapy has several advantages. It has also been shown to have positive side effects. A study recently published in the American Journal of Clinical Oncology found that cancer drugs can be highly effective in treating certain types of cancer. The effectiveness of targeted therapy depends on its ability to interfere with specific proteins and genes.
While targeting cancer cells is an important part of the treatment, it is important to remember that some of these drugs may belong to multiple groups. A drug that stops the growth of cancer cells may also be a monoclonal antibody that triggers the immune system to attack the cancer cells. These drugs are a relatively new type of cancer treatment. They are not yet widely used, and may only be available as part of a clinical trial. Targeted therapy centers can provide patients with personalized lists of clinical trials and information on molecular profiling and genetic testing. It can also provide free genetic testing and molecular profiling services.
